Work

209P Molecular atlas of copy number variation(CNV) in lung cancer with brain metastases

Year: 2023

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.2932

Authors: X. Zhang, T. Han, D. Guo, R. Kong, S. Chen, R. Ding, W. Deng, F. Bu

Institutions: First Hospital of Jilin University, Simcere Pharmaceutical (China)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, American Society of Clinical Oncology, Seagen, Genentech

OpenAlex ID: W4387809727

FWCI:

Cites:

Cited by:

Related to: 10